Latest Articles

  • Gene therapy in sickle cell disease: Possible utility and impact
    Susanna A. Curtis, MD, MS and Niketa C. Shah, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 28-29; DOI: https://doi.org/10.3949/ccjm.87a.19124

    CRISPR-Cas9 makes it possible to edit the patient’s own genes, but questions remain.

  • Fever in a traveler returning from Ethiopia
    Ken Koon Wong, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 31-42; DOI: https://doi.org/10.3949/ccjm.87a.19017

    His symptoms began about 10 days after returning and had been going on for 11 days. What was the cause?

  • In reply: How should diabetic dyslipidemia be treated?
    Ting-I Lee, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01004
  • Are we all clear? Unintended shocks to caregivers during cardiopulmonary resuscitation
    David R. Lowery, MD, FASA, Maj, MC, USA, Daniel Cantillon, MD, FACC, FHRS and Donn Marciniak, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 16-18; DOI: https://doi.org/10.3949/ccjm.87a.19022

    Defibrillators are designed to affect electrical activity in the patient’s heart. Caregivers, be careful!

  • Modifying genetic diseases: Promises to be realized?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 7-8; DOI: https://doi.org/10.3949/ccjm.87b.01020

    Genetic engineering offers hope to patients and families who previously had little.

  • Sickle cell disease: A primary care update
    Grace Onimoe, MD and Seth Rotz, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 19-27; DOI: https://doi.org/10.3949/ccjm.87a.18051

    Survival has improved, but patients still face multiorgan damage, chronic anemia, and debilitating pain crises.

  • Gabapentin for alcohol use disorder: A good option, or cause for concern?
    Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

    There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  • Vaping: The new wave of nicotine addiction
    Perry Dinardo, BA and Ellen S. Rome, MD, MPH
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 789-798; DOI: https://doi.org/10.3949/ccjm.86a.19118

    Despite perceptions that vaping is harmless and claims that it can aid in smoking cessation, risks are emerging.

  • Desquamating pustular rash
    Kevin Bryan Uy Lo, MD and Zurab Azmaiparashvili, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 780-781; DOI: https://doi.org/10.3949/ccjm.86a.19061

    The symptoms had started 3 days after the patient began using ciprofl oxacin eye drops.

  • Colorectal cancer screening
    Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001

Pages